• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体异源二聚体的结构与功能。

Structure and function of adenosine receptor heteromers.

机构信息

Molecular Neurobiology Laboratory, Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Catalonia, 08028, Barcelona, Spain.

Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos iii, Madrid, Spain.

出版信息

Cell Mol Life Sci. 2021 Apr;78(8):3957-3968. doi: 10.1007/s00018-021-03761-6. Epub 2021 Feb 12.

DOI:10.1007/s00018-021-03761-6
PMID:33580270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11072997/
Abstract

Adenosine is one of the most ancient signaling molecules and has receptors in both animals and plants. In mammals there are four specific receptors, A, A, A, and A, which belong to the superfamily of G-protein-coupled receptors (GPCRs). Evidence accumulated in the last 20 years indicates that GPCRs are often expressed as oligomeric complexes formed by a number of equal (homomers) or different (heteromers) receptors. This review presents the data showing the occurrence of heteromers formed by A and A, A and A, and A and A receptors highlighting (i) their tetrameric structural arrangements, and (ii) the functional diversity that those heteromers provide to adenosinergic signaling.

摘要

腺苷是最古老的信号分子之一,在动物和植物中都有受体。在哺乳动物中,有四种特定的受体,A、A、A 和 A,它们属于 G 蛋白偶联受体 (GPCR) 的超家族。过去 20 年积累的证据表明,GPCR 通常作为由多个相同 (同源物) 或不同 (异源物) 受体组成的寡聚体复合物表达。这篇综述介绍了表明由 A 和 A、A 和 A 以及 A 和 A 受体形成的异源二聚体存在的数据,突出了 (i) 它们的四聚体结构排列,以及 (ii) 这些异源二聚体为腺苷能信号提供的功能多样性。

相似文献

1
Structure and function of adenosine receptor heteromers.腺苷受体异源二聚体的结构与功能。
Cell Mol Life Sci. 2021 Apr;78(8):3957-3968. doi: 10.1007/s00018-021-03761-6. Epub 2021 Feb 12.
2
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.在人A2B和A3受体亚型上具有高效能的三唑并喹唑啉腺苷拮抗剂(CGS 15943)的衍生物。
J Med Chem. 1998 Jul 16;41(15):2835-45. doi: 10.1021/jm980094b.
3
Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.腺苷受体突变的结构映射:配体结合和信号转导机制。
Trends Pharmacol Sci. 2018 Jan;39(1):75-89. doi: 10.1016/j.tips.2017.11.001. Epub 2017 Dec 5.
4
Pharmacology of Adenosine Receptors: The State of the Art.腺苷受体药理学:最新进展。
Physiol Rev. 2018 Jul 1;98(3):1591-1625. doi: 10.1152/physrev.00049.2017.
5
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs.与Gi和Gs形成复合物的G蛋白偶联受体异四聚体的四级结构。
BMC Biol. 2016 Apr 5;14:26. doi: 10.1186/s12915-016-0247-4.
6
Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs.对A2a受体缺陷小鼠的分析显示,淋巴器官中A2b、A1和A3腺苷受体的表达没有显著的代偿性增加。
Biochem Pharmacol. 2003 Jun 15;65(12):2081-90. doi: 10.1016/s0006-2952(03)00158-8.
7
Purinoceptors in the nervous system.神经系统中的嘌呤受体。
Pharmacol Toxicol. 1995 Apr;76(4):228-39. doi: 10.1111/j.1600-0773.1995.tb00135.x.
8
Adenosine receptors: new opportunities for future drugs.腺苷受体:未来药物的新机遇。
Bioorg Med Chem. 1998 Jun;6(6):619-41. doi: 10.1016/s0968-0896(98)00038-8.
9
Adenosine receptor heteromers and their integrative role in striatal function.腺苷受体异聚体及其在纹状体功能中的整合作用。
ScientificWorldJournal. 2007 Nov 2;7:74-85. doi: 10.1100/tsw.2007.211.
10
Adenosine signaling and the immune system: When a lot could be too much.腺苷信号转导与免疫系统:过犹不及。
Immunol Lett. 2019 Jan;205:9-15. doi: 10.1016/j.imlet.2018.04.006. Epub 2018 Apr 24.

引用本文的文献

1
Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF receptor heterotetramer.μ-阿片受体-促肾上腺皮质激素释放因子(CRF)受体异源四聚体的独特生化特性。
Pharmacol Res. 2025 Aug 8;219:107904. doi: 10.1016/j.phrs.2025.107904.
2
Adenosine receptor subtype modulators: Insight into molecular mechanisms and their therapeutic application.腺苷受体亚型调节剂:对分子机制及其治疗应用的洞察
Am J Transl Res. 2025 Apr 15;17(4):2376-2395. doi: 10.62347/ZYVY9443. eCollection 2025.
3
Principles and Design of Molecular Tools for Sensing and Perturbing Cell Surface Receptor Activity.用于感知和扰动细胞表面受体活性的分子工具的原理与设计
Chem Rev. 2025 Mar 12;125(5):2665-2702. doi: 10.1021/acs.chemrev.4c00582. Epub 2025 Feb 25.
4
Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implications.解析肝细胞癌中的腺苷信号传导:途径、预后模型及治疗意义
Clin Mol Hepatol. 2025 Feb 5. doi: 10.3350/cmh.2024.1068.
5
Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB and Serotonin 5HT Receptors.改变大麻素CB受体与5-羟色胺5HT受体异聚化的小分子非肽配体的设计
J Med Chem. 2025 Jan 9;68(1):261-269. doi: 10.1021/acs.jmedchem.4c01796. Epub 2024 Dec 26.
6
TRPA1, TRPV1, and Caffeine: Pain and Analgesia.TRPA1、TRPV1 和咖啡因:疼痛与镇痛。
Int J Mol Sci. 2024 Jul 19;25(14):7903. doi: 10.3390/ijms25147903.
7
Adenosine A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ to Model Early Alzheimer's Disease.β淀粉样蛋白诱导的 AD 早期小鼠模型中,腺苷 A 受体上调早于突触可塑性和记忆缺陷。
Biomolecules. 2023 Jul 28;13(8):1173. doi: 10.3390/biom13081173.
8
Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.偏头痛信号通路:嘌呤代谢物调节偏头痛并使偏头痛患者易患头痛。
Mol Cell Biochem. 2023 Dec;478(12):2813-2848. doi: 10.1007/s11010-023-04701-7. Epub 2023 Mar 22.
9
New paradigms in purinergic receptor ligand discovery.嘌呤能受体配体发现的新范式。
Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13.
10
Modulating brain integrative actions as a new perspective on pharmacological approaches to neuropsychiatric diseases.调节大脑整合作用:神经精神疾病药理学方法的新视角。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1038874. doi: 10.3389/fendo.2022.1038874. eCollection 2022.

本文引用的文献

1
Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A receptor.全长及C末端截短型腺苷A受体偏向激动作用的实验与计算分析
Comput Struct Biotechnol J. 2020 Sep 24;18:2723-2732. doi: 10.1016/j.csbj.2020.09.028. eCollection 2020.
2
Adenosine A and A Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling.腺苷 A 和 A 受体能够相互作用。腺苷受体介导的信号转导之谜的又一环节。
Int J Mol Sci. 2020 Jul 17;21(14):5070. doi: 10.3390/ijms21145070.
3
Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity.腺苷/A2B 受体信号转导可改善衰老的影响并对抗肥胖。
Cell Metab. 2020 Jul 7;32(1):56-70.e7. doi: 10.1016/j.cmet.2020.06.006. Epub 2020 Jun 25.
4
Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.精神分裂症患者嗅神经上皮细胞中 CB1R-5-HT2AR 异源二聚体的信号改变受大麻使用的调节。
Schizophr Bull. 2020 Dec 1;46(6):1547-1557. doi: 10.1093/schbul/sbaa038.
5
DIMERBOW: exploring possible GPCR dimer interfaces.二聚体探索:探索可能的 G 蛋白偶联受体二聚体界面。
Bioinformatics. 2020 May 1;36(10):3271-3272. doi: 10.1093/bioinformatics/btaa117.
6
Control of glutamate release by complexes of adenosine and cannabinoid receptors.腺苷和大麻素受体复合物对谷氨酸释放的控制。
BMC Biol. 2020 Jan 23;18(1):9. doi: 10.1186/s12915-020-0739-0.
7
Structural insights into the activation of metabotropic glutamate receptors.结构洞察代谢型谷氨酸受体的激活。
Nature. 2019 Feb;566(7742):79-84. doi: 10.1038/s41586-019-0881-4. Epub 2019 Jan 23.
8
Regulation of human brown adipose tissue by adenosine and A receptors - studies with [O]HO and [C]TMSX PET/CT.腺苷和 A 受体对人棕色脂肪组织的调节作用——[O]HO 和 [C]TMSX PET/CT 的研究。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):743-750. doi: 10.1007/s00259-018-4120-2. Epub 2018 Aug 13.
9
A Receptor Activation Attenuates Hypertensive Cardiac Remodeling via Promoting Brown Adipose Tissue-Derived FGF21.一种受体的激活通过促进棕色脂肪组织来源的成纤维细胞生长因子 21 来减轻高血压性心脏重构。
Cell Metab. 2018 Sep 4;28(3):476-489.e5. doi: 10.1016/j.cmet.2018.06.013. Epub 2018 Jul 12.
10
Structure of the adenosine-bound human adenosine A receptor-G complex.人源腺苷受体-G 复合物结合腺苷的结构。
Nature. 2018 Jun;558(7711):559-563. doi: 10.1038/s41586-018-0236-6. Epub 2018 Jun 20.